Labelling machines used to affix health and usage warnings to pharmaceutical products may need adjustment in light of the incoming Human Medicines Regulations 2012.
The regulations remove much of the legislation already in place for pharmaceutical producers, replacing it with a comprehensive set of sensible guidelines.
In particular, some of the statutory warnings that have historically been applied to certain categories of medicines will no longer apply under the new rules.
This is good news in terms of the labelling machines used by producers, as it means product literature may not need to be updated as often in order to reflect changes in the wording of statutory warnings.
However, it may mean making an immediate change to the outer packaging of pharmaceutical products, to remove less-relevant statutory warnings and replace them with product-specific cautions based on research.
Newly published guidance on the government Legislation website, an online archive of updated legislation for the UK, explains the advantages for consumers.
“The Medicines and Healthcare Regulatory Agency will rely on the inclusion of warnings specific to products or classes of medicinal products as terms of marketing authorisations,” it states.
“This will allow warnings to reflect the results of user testing and be changed without the need for legislative action.”
